Frequency specific microcurrent (FSM) therapy is a form of electrical stimulation that delivers extremely low-level currents to the body, with specific frequencies targeted at particular tissues and conditions. The current used is measured in millionths of an ampere, so low that most people feel nothing during treatment. FSM is used primarily for pain management, inflammation, and tissue recovery, though its applications have expanded into areas like sleep disorders, emotional distress, and neurological symptoms.
How FSM Works
FSM is built on the principle that every cell and tissue in your body vibrates at a specific natural frequency. When tissue is injured or inflamed, that frequency shifts away from its healthy baseline. FSM uses a dual-channel microcurrent device to deliver two frequencies simultaneously: one matched to the condition being treated (such as inflammation or scarring) and another matched to the specific tissue involved (such as nerve, muscle, or tendon). The goal is to reset those disrupted frequencies and help the tissue return to normal function.
The electrical current itself is remarkably small, typically between 100 and 500 microamperes. To put that in perspective, a standard TENS unit (the type of electrical stimulation many people have seen in physical therapy offices) operates in the milliamp range, roughly 1,000 times stronger. TENS works by overwhelming pain signals so your brain doesn’t register them. FSM takes a fundamentally different approach: instead of masking pain, it aims to change the tissue environment at a cellular level.
What Happens at the Cellular Level
The most well-documented effect of microcurrent on cells involves energy production. When microcurrent in the 100 to 500 microampere range is applied to tissue, studies in both animal and human models have shown ATP production increases by three to five times normal levels. ATP is the molecule your cells use as fuel for virtually every repair and maintenance process, so a significant boost in ATP availability could accelerate healing.
Beyond energy production, microcurrent stimulation has been linked to several other cellular responses: increased protein synthesis in muscle tissue, reduced swelling, enhanced muscle cell development, and stimulation of growth and tissue restoration. One proposed mechanism involves noradrenaline, a chemical messenger that plays a role in protein building within muscles. Microcurrent appears to stimulate its release, which may help explain some of the recovery benefits practitioners report.
Conditions Treated With FSM
FSM is most commonly used for chronic pain, particularly myofascial pain (the deep, aching pain that originates in muscle and connective tissue), fibromyalgia, chronic back pain, and migraine. Practitioners also apply it for nerve injuries, skeletal system pain, and concussion-related symptoms like brain fog. More recently, pilot studies have explored its use for insomnia, anxiety, depression, and general emotional distress, with early results suggesting it may help modulate somatic symptoms by influencing inflammatory pathways.
The treatment is highly individualized. A practitioner selects frequency combinations based on your specific diagnosis. Someone being treated for fibromyalgia associated with a neck injury would receive entirely different frequency pairs than someone recovering from a concussion. This specificity is what distinguishes FSM from general microcurrent devices and is the basis for the “frequency specific” label.
What the Clinical Evidence Shows
The strongest published evidence for FSM involves inflammation and pain reduction. In a study of fibromyalgia patients with cervical spine trauma, a single 90-minute FSM session produced dramatic drops in key inflammatory markers. Interleukin-1 (a protein that drives inflammation) fell from 330 to 80 pg/ml. Interleukin-6, another inflammatory marker, dropped from 239 to 76 pg/ml. Substance P, a chemical closely tied to pain signaling, decreased from 180 to 54 pg/ml. All three changes were statistically significant, and the reductions in these blood markers corresponded with patients reporting meaningful pain relief.
Those numbers are notable because they represent changes that would be impressive even with pharmaceutical interventions. However, FSM research remains limited in scale. Most published studies are case reports, case series, or small pilot trials rather than large randomized controlled trials. The therapy has a growing base of clinical observations and plausible biological mechanisms, but the kind of large-scale evidence that would make it a standard recommendation in mainstream medicine doesn’t yet exist.
What a Session Looks Like
FSM treatment is delivered through a small desktop or portable device connected to the body via damp towels, adhesive electrode pads, or graphite gloves worn by the practitioner. Sessions typically last between 30 and 90 minutes. Because the current is so far below your sensory threshold, you won’t feel a buzzing or tingling sensation the way you would with a TENS unit. Some people report warmth, relaxation, or a sense of softening in tight tissue during treatment, but many feel nothing at all while the device is running.
Practitioners who use FSM include chiropractors, physical therapists, acupuncturists, naturopathic doctors, and some medical doctors. Training is available through continuing education courses, and the specific frequency protocols are proprietary, meaning the practitioner needs specialized training beyond simply owning a microcurrent device.
FDA Status and Safety
Microcurrent devices are FDA-cleared as transcutaneous electrical nerve stimulators, classified as Class II medical devices. This means they’ve met safety and performance standards for specific uses like pain relief, but the FDA clearance applies to the device category rather than to the specific frequency protocols that define FSM. The distinction matters: the hardware is regulated, but the particular frequency combinations and the clinical claims built around them have not been individually evaluated by the FDA.
FSM is considered safe for most people. The current is too low to cause tissue damage, and side effects are uncommon. The primary contraindications are the same as for other electrical stimulation devices: people with pacemakers, implanted defibrillators, or metallic implants in the treatment area should avoid it. Pregnant women are also typically advised against treatment. Some patients experience temporary fatigue or a mild detox-like feeling after sessions, which practitioners attribute to the release of inflammatory byproducts as tissue begins to heal.